DavidSRussellMD, PhD

Neurology • New Haven, CT

Movement Disorder, Neurodegenerative

Senior Medical Director. Clinical Research Invicro, now known as Perceptive. Assistant Clinical Professor, Yale University School of Medicine

Join to view full profile

Dr. Russell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Russell's full profile

Already have an account?

Office
60 Temple St
Suite 8B
New Haven, CT 06510
Phone+1 203-401-4300

Fax+1 203-401-4301

Education & Training

Yale-New Haven Medical CenterResidency, Neurology, 1992 - 1995
Yale-New Haven Medical CenterInternship, Internal Medicine, 1991 - 1992
Weill Cornell MedicineClass of 1991

Certifications & Licensure

CT State Medical License 1995 - 2025
PA State Medical License 1995 - 1996

Clinical Trials

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions Start of enrollment: 2009 Mar 01
Completed
Phase 1
Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
Completed
Phase 2
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo Start of enrollment: 2013 Jul 01
Terminated
Phase 3
Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects Start of enrollment: 2014 Feb 01
Completed
Phase 1
Efficacy of Isradipine in Early Parkinson Disease Start of enrollment: 2014 Nov 01
Completed
Phase 3
Systemic Synuclein Sampling Study (S4) Start of enrollment: 2015 Oct 01
Completed
Early Longitudinal Imaging in Parkinson's Progression Markers Initiative Using [¹⁸F] AV-133 and DaTscan™ Start of enrollment: 2020 Sep 10
Active, not recruiting
Join now to see all

Publications & Presentations

PubMed

Multiple sclerosis inG2019S Parkinson's disease and isolated nigral degeneration in a homozygous variant carrier.
Adina Wise, Roberto A Ortega, Deborah Raymond, Alessandra Cervera, Emma Thorn
Frontiers in Neurology. 2024-01-01
3 citations
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degeneration.
Shunsuke Koga, Michael A Metrick 2nd, Lawrence I Golbe, Alessia Santambrogio, Minji Kim
Acta Neuropathologica Communications. 2023-06-01
5 citations
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study.
James Robert Brašić, Jack Alexander Goodman, Ayon Nandi, David S Russell, Danna Jennings
Brain Sciences. 2022-02-26

Press Mentions

Patients May Wait Years for New DrugsApril 30th, 2023
20 Years of Human Embryonic Stem CellsApril 20th, 2018

Professional Memberships

International Parkinson and Movement Disorder Society - MDS
Member